Intended for healthcare professionals

Letters Gabapentinoid reclassification

Gabapentinoids: when hope is restored, it’s obvious that increasing analgesics will bring no benefit

BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m534 (Published 11 February 2020) Cite this as: BMJ 2020;368:m534
  1. David McGavin, GP with special interest in chronic pain management,
  2. Ingrid Hermansen, eurythmy therapist and trust coordinator
  1. Kairos Rehabilitation Trust, c/o Heronsgate Medical Centre, Thamesmead SE28 0ER, UK
  1. david.mcgavin{at}nhs.net

Ian Hamilton need not be so downcast about alternatives for reducing gabapentinoid use.1

Kairos Rehabilitation, a registered charity, is a pain management clinic led by a GP with specialist interest, commissioned by Circle MSK for Greenwich Clinical Commissioning Group. We have furnished Hamilton’s call for “more support” with gentle therapies, …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription